- Report
- August 2023
- 147 Pages
Global
From €7196EUR$7,500USD£6,198GBP
- Report
- August 2022
- 105 Pages
Global
From €4558EUR$4,750USD£3,925GBP
- Report
- August 2021
- 55 Pages
Global
From €6712EUR$6,995USD£5,781GBP
- Report
- November 2020
- 225 Pages
Global
From €10550EUR$10,995USD£9,086GBP
- Report
- February 2020
- 231 Pages
Global
From €3454EUR$3,600USD£2,975GBP
Signifor is a class of drugs used to treat endocrine and metabolic disorders. These drugs are used to treat conditions such as Cushing's disease, acromegaly, and pituitary tumors. They work by blocking the production of hormones that cause these conditions. Signifor drugs are typically administered as injections, and can be used in combination with other treatments.
Signifor drugs are used to treat a variety of endocrine and metabolic disorders, including Cushing's disease, acromegaly, and pituitary tumors. They are also used to treat certain types of cancer, such as adrenocortical carcinoma. Signifor drugs are typically administered as injections, and can be used in combination with other treatments.
Some companies in the Signifor market include Novartis, Pfizer, and Merck. These companies produce and market Signifor drugs for the treatment of endocrine and metabolic disorders. Show Less Read more
